Genetically engineered bananas, packed with micronutrients, are to undergo their first human trial in the United States to test their ability to battle rampant vitamin A deficiency — a large cause of infant death and blindness throughout low-income communities around the world.
“The consequences of vitamin A deficiency are dire with 650,000 to 700,000 children worldwide dying … each year and at least another 300,000 going blind,” the project leader, Professor James Dale from Australia’s Queensland University of Technology, told AFP.
The six-week trial backed by the Bill and Melinda Gates Foundation expects to have results by the end of the year and plans to have the bananas growing in Uganda by 2020.
Standard Ugandan bananas provide sustenance to East Africa but have low levels of nutrients such as iron and vitamin A. “Good science can make a massive difference here by enriching staple crops such as Ugandan bananas with pro-vitamin A and providing poor and subsistence-farming populations with nutritionally rewarding food,” said Dale.
Researchers infused the staple crop in Uganda with alpha- and beta-carotene — which the body turns into vitamin A — as an easy solution to the problem that plagues the country, but the same modification could be used on different crops as well. If the bananas are approved for growth in Uganda, other staple crops in Rwanda, Tanzania and Kenya could also be engineered with micronutrients.
“In West Africa farmers grow plantain bananas and the same technology could easily be transferred to that variety as well,” Dale said.